60
Participants
Start Date
October 29, 2024
Primary Completion Date
May 31, 2028
Study Completion Date
May 31, 2028
Creatine
Those randomized to receive creatine (experimental group) will be initially dosed at 20 g/day for 7 days to boost availability of creatine systemically. Thereafter, the dose will be reduced to 5 g/day for maintenance through the duration of the 12-week protocol.
RECRUITING
The University of Texas Medical Branch, Galveston, Galveston
ThriveWell Cancer Foundation
UNKNOWN
The University of Texas Medical Branch, Galveston
OTHER